GBI Research

198 products published

GBI Research

198 products published

GBI Research is a leading provider of market information studies based on the healthcare sector. Offering a mix of product pipeline analysis, benchmarking and market digests as well as overall market overviews, GBI Research provide invaluable information for any company operating within the healthcare and pharmaceutical industries. Employing a truly unique method of primary data collection, overseen by their team of experienced researchers, GBI Research are able to provide market-leading solutions that can help your company stay at the very top of the industry.

Blood Pressure Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Blood Pressure Disorders Drug Development Pipeline Review, 2018

  • Report
  • 213 Pages
From
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018

  • Report
  • 385 Pages
From
Respiratory Tract Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Respiratory Tract Infections Drug Development Pipeline Review, 2018

  • Report
  • 153 Pages
From
Diarrhea and Constipation Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diarrhea and Constipation Drug Development Pipeline Review, 2018

  • Report
  • 93 Pages
From
Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018

  • Report
  • 98 Pages
From
Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer - Product Thumbnail Image

Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer

  • Report
  • 122 Pages
From
Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline - Product Thumbnail Image

Global Cancer Immunotherapies Market to 2024 - Increased Uptake of Immune Checkpoint Inhibitors Driving Growth, Supported by a Large, Robust Pipeline

  • Report
  • 215 Pages
From
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market - Product Thumbnail Image

Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2024 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • Report
  • 152 Pages
From
Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Ongoing Transition from Anti-Resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness. - Product Thumbnail Image

Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Ongoing Transition from Anti-Resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness.

  • Report
  • 138 Pages
From
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

  • Report
  • 344 Pages
From
Menopausal Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Menopausal Disorders Drug Development Pipeline Review, 2018

  • Report
  • 84 Pages
From
Hepatitis Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Hepatitis Drug Development Pipeline Review, 2018

  • Report
  • 133 Pages
From
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market - Product Thumbnail Image

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

  • Report
  • 125 Pages
From
Influenza A Viral Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Influenza A Viral Infections Drug Development Pipeline Review, 2018

  • Report
  • 188 Pages
From
Mosquito-borne Diseases Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Mosquito-borne Diseases Drug Development Pipeline Review, 2018

  • Report
  • 142 Pages
From
Ocular Cancer Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Ocular Cancer Drug Development Pipeline Review, 2018

  • Report
  • 63 Pages
From
Inflammatory Skin Diseases Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Inflammatory Skin Diseases Drug Development Pipeline Review, 2018

  • Report
  • 112 Pages
From
Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms - Product Thumbnail Image

Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms

  • Report
  • 68 Pages
From
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence - Product Thumbnail Image

Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence

  • Report
  • 215 Pages
From
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018

  • Report
  • 82 Pages
From
Loading Indicator
adroll